ZA961234B - Method of lessening the risk of vertebral and non-vertebral fractures - Google Patents

Method of lessening the risk of vertebral and non-vertebral fractures

Info

Publication number
ZA961234B
ZA961234B ZA961234A ZA961234A ZA961234B ZA 961234 B ZA961234 B ZA 961234B ZA 961234 A ZA961234 A ZA 961234A ZA 961234 A ZA961234 A ZA 961234A ZA 961234 B ZA961234 B ZA 961234B
Authority
ZA
South Africa
Prior art keywords
vertebral
lessening
risk
fractures
vertebral fractures
Prior art date
Application number
ZA961234A
Other languages
English (en)
Inventor
David B Karpf
Thomas P Capizzi
Hui Quan
Arthur C Ii Santora
Ashley J Yates
William J Polvino
Deborah R Shapiro
Desmond E Thompson
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA961234B publication Critical patent/ZA961234B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA961234A 1995-02-17 1996-02-16 Method of lessening the risk of vertebral and non-vertebral fractures ZA961234B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/389,860 US20010051616A1 (en) 1995-02-17 1995-02-17 Method of lessening the risk of vertebral fractures

Publications (1)

Publication Number Publication Date
ZA961234B true ZA961234B (en) 1996-08-27

Family

ID=23540050

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961234A ZA961234B (en) 1995-02-17 1996-02-16 Method of lessening the risk of vertebral and non-vertebral fractures

Country Status (14)

Country Link
US (1) US20010051616A1 (fr)
EP (1) EP0809503A4 (fr)
JP (1) JPH11501906A (fr)
KR (1) KR19980702209A (fr)
CN (1) CN1181008A (fr)
AU (1) AU689379B2 (fr)
CA (1) CA2213076A1 (fr)
EA (1) EA000348B1 (fr)
HU (1) HUP9802077A3 (fr)
NZ (1) NZ303476A (fr)
PL (1) PL321836A1 (fr)
SK (1) SK111697A3 (fr)
WO (1) WO1996025166A1 (fr)
ZA (1) ZA961234B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
AU1525700A (en) * 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
KR100317935B1 (ko) * 1999-10-20 2001-12-22 유승필 대사성 골질환 치료용 약제조성물 및 이의 제조방법
MXPA04006027A (es) * 2001-12-21 2004-09-27 Procter & Gamble Metodo para el tratamiento de trastornos de los huesos.
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP2172192A1 (fr) * 2001-12-24 2010-04-07 Teva Pharmaceutical Industries Ltd. Forme de dosage dotée d'un comprimé central d'ingrédient actif insérée dans un corps annulaire comprimé de poudre de matériau granulaire et procédé et outillage pour la produire
KR20140021045A (ko) * 2002-05-10 2014-02-19 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
JP4427453B2 (ja) 2002-12-20 2010-03-10 エフ．ホフマン−ラ ロシュ アーゲー 高用量イバンドロネート製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
EP0600834A1 (fr) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Utilisation de dérivés de l'acide méthanediphosphonique pour la fabrication d'un médicament pour le traitement de fractures
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery

Also Published As

Publication number Publication date
JPH11501906A (ja) 1999-02-16
AU689379B2 (en) 1998-03-26
EP0809503A1 (fr) 1997-12-03
KR19980702209A (ko) 1998-07-15
MX9706275A (es) 1997-11-29
CN1181008A (zh) 1998-05-06
PL321836A1 (en) 1997-12-22
EA000348B1 (ru) 1999-04-29
SK111697A3 (en) 1998-02-04
CA2213076A1 (fr) 1996-08-22
EP0809503A4 (fr) 2001-12-05
HUP9802077A3 (en) 2001-10-29
NZ303476A (en) 2000-07-28
HUP9802077A2 (hu) 2000-06-28
EA199700185A1 (ru) 1997-12-30
AU4979996A (en) 1996-09-04
US20010051616A1 (en) 2001-12-13
WO1996025166A1 (fr) 1996-08-22

Similar Documents

Publication Publication Date Title
EP0724409A4 (fr) Extenseur intramedullaire pour des os et procede d'utilisation de celui-ci
SG32522A1 (en) Surface treatment method and system
PL318128A1 (en) Polymer-polyol and method of obtaining polymer-polyols
EP0996632A4 (fr) Fragments d'angiostatine et leur procede d'utilisation
ZA965088B (en) Methods of preventing or treating allergles
GB9407135D0 (en) Treatment of osteoporosis
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
GB9412967D0 (en) Disposable receptacle and method of forming the same
SK128197A3 (en) Method of producing chocolate or similar mass and their use
EP0809502A4 (fr) Procede de diminution des risques de fractures osseuses autres que les fractures vertebrales
GB9617780D0 (en) Method of treatment
ZA9610901B (en) Treatment and prophylaxis of osteoporosis
GB9520615D0 (en) Method of preventing bone loss
HUP9801990A3 (en) Peptide and method of obtaining it
ZA989207B (en) Method of building and maintaining bone.
EP0711168A4 (fr) Procedes de traitement de l'apoptose et d'etats associes
ZA931778B (en) Method and composition for the treatment of osteoporosis
IL116142A0 (en) Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
ZA961234B (en) Method of lessening the risk of vertebral and non-vertebral fractures
GB9706070D0 (en) Method of decomposing polychlorodibenzo-p-dioxins and/or polychlorodibenzofurans
EP1031323A4 (fr) Dispositif de fixation d'os et procede de fabrication dudit dispositif
PL301204A1 (en) Method of obtaining avermectines and invermectines
IL117077A0 (en) Method of lessening the risk of vertebral and non-vertebral fractures
GB9618341D0 (en) Method of treatment
IL111069A (en) System and method of visual orientation